Trifluridine and Tipiracil
LONSURF
Nucleoside Analog Antiviral
NADAC/unit
N/A
No Shortage
Tier 1: 35.9%
PA Req: 198.2%
2 Manufacturers
4 ANDAs
Generic Manufacturers
MSN LABORATORIES PRIVATE LTDNATCO PHARMA LTDTAIHO ONCOLOGY INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
